Obestat (Sibutramine 15mg): Cipla Generic of a Withdrawn Appetite Suppressant and Its Safer Alternatives

Obestat (Sibutramine 15mg) represents the serotonin-norepinephrine reuptake inhibitor (SNRI) weight loss medication providing central appetite suppression through modulation of brain neurotransmitters. Originally developed by Knoll Pharmaceuticals (later Abbott) and FDA-approved as Meridia in 1997 (also marketed as Reductil in Europe), sibutramine was a widely used weight loss medication for over a decade. IMPORTANT REGULATORY STATUS: Following the SCOUT Trial (Sibutramine Cardiovascular Outcomes) demonstrating 16 percent increased cardiovascular events (myocardial infarction, stroke, resuscitated cardiac arrest, cardiovascular death), sibutramine was withdrawn from the European market in January 2010 by EMA recommendation and voluntarily withdrawn from the US market in October 2010 by Abbott. Currently, no major regulatory authority approves sibutramine, though generic formulations continue production in India (as Obestat by Cipla) for select markets. This product requires careful cardiovascular risk assessment, baseline evaluation, and blood pressure monitoring throughout any treatment attempt.
Sibutramine works through serotonin-norepinephrine reuptake inhibition — similar mechanism to SNRI antidepressants (venlafaxine, duloxetine) but with weight loss as primary therapeutic effect. First, sibutramine enhances central satiety signaling through increased serotonin and norepinephrine in appetite regulation centers. Second, it reduces food intake by increasing feeling of fullness with smaller portions. Third, sibutramine produces modest thermogenic effect increasing metabolic rate. Fourth, it may improve lipid profile and glycemic control beyond direct weight loss effects. Clinical trials demonstrated 5-10 percent weight loss over 1 year with improved metabolic parameters.
Obestat was originally indicated for obesity treatment (BMI over 30) and overweight (BMI over 27) with comorbid conditions. Given the regulatory withdrawal status and cardiovascular safety concerns, current use requires careful patient selection with no cardiovascular disease history and comprehensive baseline evaluation. Safer alternatives including Lodonak BP (naltrexone-bupropion, FDA-approved 2014), GLP-1 agonists (Wegovy, Saxenda), and orlistat should be considered first-line.
Obestat dosed 10-15 mg once daily in morning. Requires baseline cardiovascular evaluation. Blood pressure and heart rate monitoring mandatory. Discontinue if BP or HR sustained increase. Contraindicated with cardiovascular disease.
Free prescription
Discrete packaging
Have questions?
Quality Assurance
- Obesity Treatment: BMI over 30 in adults - originally approved indication before regulatory withdrawal;
- Overweight with Comorbid Conditions: BMI over 27 with cardiovascular risk factors dyslipidemia or type 2 diabetes;
- Appetite Suppression: Central serotonin-norepinephrine reuptake inhibition reduces appetite and food intake;
- Satiety Enhancement: Enhanced feeling of fullness with smaller portions supporting reduced-calorie diet compliance;
- Cholesterol Normalization: Improved lipid profile documented in clinical trials beyond weight loss effects;
- Metabolic Parameter Improvement: Improved lipids glucose and insulin sensitivity as secondary weight loss effects;
- Type 2 Diabetes with Obesity: Weight reduction in diabetic patients improving HbA1c and cardiovascular risk profile;
- Dyslipidemia with Obesity: Weight loss adjunct improving lipid abnormalities in obese patients;
- Failed Lifestyle Intervention Patients: Patients who have exhausted diet and exercise interventions without adequate weight reduction;
- SNRI Weight Loss Class: Unique mechanism as serotonin-norepinephrine reuptake inhibitor with weight loss indication;
- Central Appetite Suppression: Direct central nervous system modulation of appetite regulation centers through neurotransmitter enhancement;
- Portion Control Support: Enhanced satiety enables easier portion control during reduced-calorie diet;
- Thermogenic Effect: Modest increase in metabolic rate contributing to energy expenditure;
- Non Amphetamine Appetite Suppressant: Different mechanism from amphetamine-type appetite suppressants without stimulant abuse potential;
- Long Term Weight Management: Sustained therapy supports weight maintenance beyond initial loss period;
- Metabolic Syndrome Component: Weight loss addresses metabolic syndrome multiple risk factors;
- HbA1c Reduction in Diabetics: Improved glycemic control observed in type 2 diabetes with weight loss;
- Waist Circumference Reduction: Reduced central adiposity contributing to cardiovascular risk reduction;
- Generic Sibutramine Therapy: Bioequivalent Cipla generic alternative to withdrawn brand Meridia/Reductil at accessible cost.
- Normalizes Cholesterol Level: Improved lipid profile documented in clinical trials beyond weight loss effects providing cardiovascular benefits;
- Better Appetite Suppression: Central SNRI mechanism enhances satiety making adherence to reduced-calorie diet easier and more sustainable;
- Better Satiety Enhancement: Enhanced feeling of fullness with smaller portions supports natural reduction in food intake;
- Better Portion Control: Reduced appetite enables easier portion control and adherence to dietary recommendations;
- Better Thermogenic Effect: Modest increase in metabolic rate contributes additional energy expenditure supporting weight loss;
- Non Amphetamine Approach: Different mechanism from stimulant appetite suppressants without amphetamine-type abuse potential;
- Better HbA1c Improvement: Improved glycemic control in diabetic patients providing dual metabolic benefit beyond weight loss;
- Better Metabolic Parameter Improvement: Comprehensive improvement in metabolic parameters including lipids glucose and insulin sensitivity;
- Better Waist Circumference Reduction: Reduced central adiposity beyond overall weight loss addressing cardiovascular risk from visceral fat;
- Better Once Daily Dosing: Simple once daily morning dosing schedule improves treatment adherence during weight loss protocols;
- Better Comprehensive Obesity Approach: Combined with diet and exercise provides comprehensive weight loss support beyond lifestyle alone;
- Better SNRI Mechanism: Unique serotonin-norepinephrine reuptake inhibition mechanism different from combination or single-mechanism weight loss drugs;
- Better Long Term Weight Management: Sustained therapy supports maintenance of weight loss when tolerated and appropriate;
- Better Diabetic Weight Loss Component: Particularly beneficial for type 2 diabetics where weight reduction improves multiple diabetes parameters;
- Better Reduced Insulin Resistance: Weight loss improves insulin sensitivity providing benefit for prediabetic and diabetic patients;
- Better Serotonergic Satiety Enhancement: Serotonin pathway modulation particularly effective for reducing carbohydrate cravings and emotional eating;
- Better Failed Lifestyle Intervention Alternative: Pharmacological support for patients whose diet and exercise interventions alone have proven inadequate;
- Better Cipla Manufacturing Quality: WHO-GMP US FDA-inspected facilities ensure consistent bioequivalent generic quality standards;
- Better Quality of Life: Successful weight loss dramatically improves quality of life when achieved without cardiovascular adverse events.
Generic Obestat (Obestat 15 mg) Medication guide:
What are the pills you can buy under the commercial name Obestat? When are these pills used?
The brand name Obestat is utilized for the active substance named Sibutramine. Sibutramine is the formulation that helps people to lose excessive weight as it acts as appetite suppressing agent. It was discovered back in 1988 and is now made by different companies.
However, if you are slightly chubby you should not buy Obestat as it is developed to assist individuals who suffer from the obesity and have the body mass index over thirty or twenty-seven but with the accompanying diseases such as diabetes type II, and other disorders associated with the high body mass.
How Obestat renders its effect?
The medication’s effect on weight loss is due to its inhibitory effect on the reuptake of serotonin and noradrenaline. Through this, Obestat lowers the appetite and enhances the sense of saturation in the smaller intake of food, increases thermogenesis, and contributes to the reduction on the long-stored fat tissue.
The weight reduction that occurs with the use of Obestat is associated by the elevation of the high-density lipoproteins (“good” cholesterol), the lowering of total cholesterol, triglycerides, low-density lipoproteins, and uric acid.
In people with normal blood pressure, during the therapy is observed an insignificant increase in the arterial pressure. But if the drug is combined with the inhibitors of microsomal oxidation, the risk of cardiovascular negative reactions increases.
When the medication is taken, 77% of it is quickly absorbed from the digestive tract. It is then metabolized in the liver with the effect of the CYP3A4 enzyme with the formation of two active metabolites.
The maximum concentration of the medication in the blood plasma is achieved in three to four hours. The intake of the medication with food lowers the effect of metabolites and increases the time of the maximum concentration achievement.
The equilibrium concentration of active metabolites in the blood is reached within 4 days after the start of treatment and approximately 2 times higher than the plasma level after taking a single dose.
The active metabolites undergo hydroxylation and conjugation with the formation of inactive metabolites which are excreted mainly by the kidneys.
When is Obestat contraindicated to be used?
You must not buy Generic Obestat if you are sensitive to the drug’s components, if you have organic causes for the weight gain (for instance, hormonal imbalance), if you are diagnosed with anorexia or bulimia, mental illnesses, Tourette's syndrome, any heart disease, any diseases of the blood vessels, veins, or arteries; raised blood pressure, thyroid gland dysfunction, severe impairment of the liver or renal function, enlargement of the prostate accompanied by residual urine, atonic bladder, glaucoma, alcohol or drug dependence, concurrent administration or period less than two weeks after the abolition of MAO inhibitors or other drugs acting on the CNS, as well as other drugs to reduce body weight.
Besides, the medication is highly not encouraged to be used during pregnancy or breastfeeding period because its safety in these categories of patients hadn’t been sufficiently studied.
The limited, cautious, or undesired use of the medication is in the presence of epilepsy, motor-verbal tic (involuntary muscle contraction, articulation impairment), in children and the elderly people (safety and efficacy in children under 18 years of age and in people older than 65 years is not defined).
Is there a difference when you buy generic or the branded drug?
There is no difference in the efficiency and safety of the medications with the same composition and effect if they are made by different manufacturers. However, if you buy Sibutramine under a new to you commercial name, make sure to check that the active substance of the medication is Sibutramine and the amount of it per pill is the same as in the original drug.
What adverse effects can Obestat use cause?
The most common adverse effects that are associated with the drug use are a headache, anorexia, insomnia, dry mouth, constipation, and blood pressure elevation. Other side effects such as nausea, vomiting, allergic reaction, and others can also develop. If you start developing any side effects and especially the ones related to the blood pressure or heart function or allergic reactions, stop using the pills immediately and seek medical consultation.
Can Obestat be taken with other medicines?
When you buy Generic Sibutramine, you need to check that you don’t use any medicines that must not be used with it. They include MAO inhibitors, antidepressants, neuroleptics, tryptophan, and other medicines used to lower the body weight.
The inhibitors of microsomal oxidation, including inhibitors of CYP3A4 cytochrome P450 such as ketoconazole, erythromycin, cyclosporine, and others reduce the clearance of Sibutramine and can contribute to the development of cardiovascular adverse effects. Therefore, they are not recommended to be taken along with this weightless drug.
The medication is also not advised to be used with medications that increase serotonergic transmission as it can cause the occurrence of a rare yet dangerous condition called serotonin syndrome that is characterized with agitation, increased sweating, diarrhea, fever, arrhythmia, seizures, and so on.
It is not recommended to take Obestat or its analogs along with any medicines that contribute to the elongation of the QT interval, medications that contain ephedrine, phenylpropanolamine, and pseudoephedrine.
If you use any other medications not listed here, please consult your doctor before you order Obestat and start taking the pills to make sure that you won’t be using any potentially dangerous combination of medicines.
How should you use Obestat?
First of all, before you start the therapy with the drug, you need to undergo a comprehensive checkup to exclude all conditions in which the use of this medicine is contraindicated. Secondly, you need to consult your therapist of nutritionist whether it is safe or not to take Obestat with the other preparations that you use if you use any. Then, if you don’t have any contraindications for its use, you can order Generic Obestat and use it by one 10 mg pill once a day in the morning before a meal. If you develop mild to moderate side effects, you can lower the dose to 5 mg a day.
If the effect of the medication is insufficient but you don’t suffer from any side effect, after four weeks of the therapy, the daily dose can be elevated to 15 mg taken once a day. The maximum treatment course duration is one year without interruptions (the period of use of 15 mg a day should be short).
Please note that the use of the mediation is reasonable only in the case that all other measures to lower your weight failed or deemed insufficiently effective. The treatment must be undergoing under a supervision of a doctor who has an experience of obesity treatment by a complex therapy, i.e. dietary means, eating habits change, lifestyle change, and so on.
Precautions to follow during the therapy with Obestat
During the therapy with the medication, it is important to monitor the arterial pressure and heart frequently to notice if the medication contributes to any cardiovascular adverse effects timely.
The medication must be cautiously used in hypokalemia and hypomagnesemia, and in a malfunction of the liver and kidneys of mild and moderate severity.
If during the therapy you develop chest pains, progressing shortness of breath, and swelling of the legs, it can be a signed of lung hypertension and requires medical assistance.
Women of childbearing age must ensure that they use reliable birth control means while taking Obestat as the mediation is prohibited to be used in pregnant women.
The use of the drug can reduce salivation and contribute to the development of caries, periodontal diseases, candidiasis, and discomfort in the oral cavity. During the period of treatment, it is recommended to limit the use of alcohol.
Obestat is not recommended to be used by drivers or people whose work requires increased concentration of attention.
Overdose
If you overdose, you can develop severe side effects. The most common ones are irregular heartbeat; elevate blood pressure, headache, and dizziness.
At home you can take a sorbent drug if you have it, then, seek medical assistance.
Where can you buy Obestat?
The drug is available currently only in some countries so it’s safe to say that the best place to get is an online drugstore situated in one of those countries. We offer you to order Sibutramine at an affordable price and with the delivery to your doorstep wherever you live.
Shipping of Obestat
Order your pills without any fear you will get your parcel wherever you live as we ship worldwide.







